The Canon CR-2 Digital Non-Mydriatic Retinal Camera
(Canon USA, Inc., Lake Success, NY) has received 510(k)
clearance from the FDA. The CR-2 integrates the latest in
Canon’s retinal imaging technology and enhancements in
a compact frame and is the li…
VisionCare’s AMD Telescope Wins Award
The Implantable Miniature Telescope (IMT; VisionCare
Ophthalmic Technologies, Inc., Saratoga, CA) was recently named “Best of What’s New” 2010 by Popular
Science magazine. Created by Isaac Lipshitz, MD, the
miniature device is designed to improve…
FDA Permits Stem Cell Clinical Trial for Stargardt to Begin
Advanced Cell Technology, Inc. (Santa Monica, CA), has
received clearance from the FDA to conduct a phase 2/3
clinical trial using retinal pigment epithelium (RPE) cells
derived from human embryonic stem cells to treat patients
with Stargardt macular d…
Eyetech Awarded Grant for Extended-Release Formulation of Macugen
Eyetech Inc. (Palm Beach Gardens, FL) has been awarded
a $245,000 grant to support the development of an
extended-release formulation of pegaptanib sodium
injection (Macugen) using microparticles technology,
according to a company news release.
At the …
Pegaptanib Maintained Vision Gains at 2 Years
Pegaptanib sodium injection (Macugen, Eyetech, Inc.)
significantly improved vision in patients with DME and
maintained and expanded vision gains in patients over a
2-year period, according to phase 3 data presented by
Marla B. Sultan, MD, MBA, at the A…
VEGF Trap-Eye Noninferior to Ranibizumab in Two Phase 3 Trials
In patients with wet age-related macular degeneration
(AMD), all regimens of aflibercept (VEGF Trap-
Eye, Regeneron), including aflibercept dosed every
2 months, achieved the primary endpoint compared
with ranibizumab (Lucentis, Genentech) dosed every
…